Twist Bioscience Officer Files Minor Sale to Cover Tax Bill
Twist Bioscience Corp
Subscribe to track TWST
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Twist Bioscience Officer Files Minor Sale to Cover Tax Bill
Company: Twist Bioscience Corp (TWST) Form: 144 | Filed: 2025-11-03 Significance: Low
Insider: Finn Patrick John Title: Officer | Relationship: Officer
Transaction: • Type: Proposed Sale (Sell-to-Cover) • Shares: 2,755 • Value: ~$88,379 • Price: ~$32.08
Key Insight: This is a routine, low-value "sell-to-cover" transaction to meet tax obligations from vested stock. It represents a negligible fraction of the company's market cap and is not a discretionary sale reflecting insider sentiment.
Comprehensive Analysis
SEC Filing Analysis: Twist Bioscience Corp (TWST)
Executive Summary
- Trading Significance: Low
- Key Takeaway: An officer of Twist Bioscience filed a notice of a proposed sale of shares valued at approximately $88,000. The filing indicates the sale is intended to cover tax obligations from vested equity awards, making it a non-discretionary event.
- Market Impact: The transaction is immaterial, representing a negligible percentage of the company's market capitalization and shares outstanding. No significant market impact is expected.
Company Information
| Field | Value |
|---|---|
| Company | Twist Bioscience Corp |
| Ticker Symbol | TWST |
| CIK | 0001581280 |
| Industry | BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) |
Insider Information
| Field | Value |
|---|---|
| Name | Finn Patrick John |
| CIK | 0001755970 |
| Title/Position | Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 144 (Notice of Proposed Sale) |
| Transaction Date | 2025-11-03 (Approximate Sale Date) |
| Transaction Code | Not Applicable |
| Security Type | Common |
| Shares Involved | 2,755 |
| Price Per Share | ~$32.08 (Calculated) |
| Total Value | $88,378.75 |
| Shares Owned After | Not Available |
| Ownership Type | Not Specified |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $88,378.75 |
| % of Market Cap | 0.0044% |
| Shares Transacted | 2,755 |
| % of Shares Outstanding | 0.0046% |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The transaction value of $88,379 is insignificant relative to Twist Bioscience's market capitalization of $1.99 billion.
- Transaction Significance: The sale represents less than 0.01% of both the market cap and the total shares outstanding, falling well below any threshold for moderate or high significance. The non-discretionary nature of the sale (to cover taxes) further diminishes its importance as a market signal.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction is a pre-planned, non-discretionary "sell-to-cover" event. Its small size relative to the company's market cap makes it highly unlikely to influence stock price.
Volume & Sentiment
- Expected Volume Impact: Negligible. The number of shares is too small to impact daily trading volume in a meaningful way.
- Sentiment Indicator: Neutral. Tax-related sales are common and do not typically reflect an insider's outlook on the company's future performance.
Additional Context
Transaction Notes
- Special Circumstances: The filing's remarks explicitly state, "Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution." This confirms the sale is for tax-withholding purposes.
- Recent History: The filing also discloses that the same insider has sold shares multiple times in the preceding three months, totaling approximately 48,828 shares for ~$1.53 million. While this indicates a pattern of selling, each individual transaction, including the current proposed sale, remains small in the context of the company's overall size.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
